Brief: Strides Pharma Science Ltd Dec-Quarter Consol Net Profit 2.02 Billion Rupees
30/01/2026 07:31
Jan 30 (Reuters) - Strides Pharma Science Ltd SRID.NS: STRIDES PHARMA SCIENCE LTD - DEC-QUARTER CONSOL NET PROFIT 2.02 BILLION RUPEES STRIDES PHARMA SCIENCE LTD DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 11.95 BILLION RUPEES Further company coverage: SRID.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees